000 01568 a2200409 4500
005 20250515103528.0
264 0 _c20080304
008 200803s 0 0 eng d
022 _a1090-2104
024 7 _a10.1016/j.bbrc.2007.12.157
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEllis, D J P
245 0 0 _aHistone acetylation is not an accurate predictor of gene expression following treatment with histone deacetylase inhibitors.
_h[electronic resource]
260 _bBiochemical and biophysical research communications
_cMar 2008
300 _a656-62 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcetylation
_xdrug effects
650 0 4 _aCarcinoma
_xdrug therapy
650 0 4 _aCell Line, Tumor
650 0 4 _aChromatin
_xchemistry
650 0 4 _aChromatin Immunoprecipitation
650 0 4 _aCyclin-Dependent Kinase Inhibitor p21
_xgenetics
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aGene Expression
_xdrug effects
650 0 4 _aHT29 Cells
650 0 4 _aHistone Deacetylase Inhibitors
650 0 4 _aHistones
_xchemistry
650 0 4 _aHumans
650 0 4 _aLysine
_xmetabolism
650 0 4 _aPromoter Regions, Genetic
_xdrug effects
650 0 4 _aProto-Oncogene Proteins pp60(c-src)
_xgenetics
650 0 4 _aTranscription, Genetic
_xdrug effects
700 1 _aLawman, Z K
700 1 _aBonham, K
773 0 _tBiochemical and biophysical research communications
_gvol. 367
_gno. 3
_gp. 656-62
856 4 0 _uhttps://doi.org/10.1016/j.bbrc.2007.12.157
_zAvailable from publisher's website
999 _c17689780
_d17689780